DSGN Tingkat bathi adhedhasar bathi reged Design Therapeutics Inc

Lambang korporat lan logo Design Therapeutics Inc (DSGN)

Design Therapeutics management relies on external venture financing due to a lack of stable cash flows. The gross profit margin illustrates the results of this strategy, and this metric stands at 0.00. Strong pricing power is driven by the uniqueness of GeneTAC technologies, while diversification through the development of targeted treatments for genetic pathologies minimizes the company's risks.

Tingkat bathi miturut bathi reged: Design Therapeutics (DSGN) kanggo 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar designtx.com (DSGN)

- nilai pasar lan prakiraan target analis:
Pambiji fundamental:DSGN, Design Therapeutics Inc
Barang unggulan Design Therapeutics

For the high-tech genetic medicine business of Design Therapeutics (DSGN), the gross profit margin reflects the efficiency of commercializing innovative molecules relative to their synthesis costs. This ratio measures the portion of revenue minus direct costs, where steady growth confirms the scalability of the therapy, while a sharp decline signals critical expenses and risks to capital.

Pesaing utama

Tingkat bathi miturut bathi reged Tempus AI Inc|QGEN (Qiagen NV) - Margin reged|Tingkat bathi miturut bathi reged Ionis Pharma (IONS)|Rentabilitas reged Repligen Corp (RGEN)|RNA - Margin bathi reged|crisprtx.com - Tingkat bathi miturut bathi reged|Tingkat bathi reged WGS|RARE - Rentabilitas reged|Beam Tx (BEAM) - Tingkat bathi miturut bathi reged|SRPT (Sarepta Therapeutics Inc) - Tingkat bathi miturut bathi reged|TWST: Rasio bathi reged|TXG (10xgenomics.com) - Margin reged|NTLA (Intellia Therapeutics, Inc.) - Rasio bathi reged|Rentabilitas reged Stoke Corp (STOK)|Rentabilitas dodolan miturut bathi reged BioLife|Margin reged WVE (Wave Life Sciences Ltd)|MAZE: Rentabilitas dodolan reged|Sionna Therapeutics, Inc. - Margin reged|Tingkat bathi reged PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Tingkat bathi miturut bathi reged|QURE - Rentabilitas dodolan miturut bathi reged|MGTX (MeiraGTx Corp) - Margin reged|Margin bathi reged REGENXBIO Inc. RGNX|Rentabilitas reged Solid Biosciences (SLDB)|Ocugen Corp - Rentabilitas dodolan reged|Rentabilitas reged Pacific Biosciences PACB|Rasio bathi reged BNTC (Benitec)|RCKT: Tingkat bathi miturut bathi reged|FDMT - Margin reged|LXEO: Margin reged|Korro Bio Inc. - Tingkat bathi reged|EDIT (editasmedicine.com) - Margin reged|Rentabilitas reged SLN|Rentabilitas reged ProQR Therapeutics NV (PRQR)|Codexis - Rentabilitas dodolan reged|Rentabilitas reged Sangamo SGMO|NAUT: Rentabilitas dodolan reged|MGX: Tingkat bathi miturut bathi reged|Margin bathi reged Precision BioSciences|GBIO (generationbio.com) - Tingkat bathi miturut bathi reged|Margin bathi reged boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Margin reged|Rentabilitas dodolan reged IMNN (Imunon, Inc.)|Margin reged PHIO|MBIO - Margin bathi reged|Margin reged RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Margin bathi reged|Applied DNA - Margin reged|Margin bathi reged Bluebird Bio|ImmunoPrecise (IPA) - Rentabilitas reged|Tingkat bathi adhedhasar bathi reged OMGA (Omega)|Rentabilitas reged Singular Genomics Systems|Margin bathi reged regulusrx.com RGLS|Rentabilitas reged Syros Pharmaceuticals Inc. (SYRS)|Rentabilitas dodolan miturut bathi reged Codex DNA|Rentabilitas reged TRACON TCON|Unity Biotechnology, Inc - Rentabilitas reged